Skip to main content
Aurobindo Pharma Limited (NSE:AUROPHARMA)
India flag India · Delayed Price · Currency is INR
1,157.00
-40.10 (-3.35%)
May 8, 2025, 3:29 PM IST

Revenue by Product

Fiscal year is April - March.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Mar '23 Mar '22 Mar '21 Mar '20 Mar '19
Generic Pharmaceuticals and Related Services
 		282.23B
Log In
Log In
Log In
Log In
Generic Pharmaceuticals and Related Services Growth
 		17.09%
Log In
Log In
Log In
Log In
Services
4.81B
Log In
Log In
Log In
Log In
Services Growth
-6.15%
Log In
Log In
Log In
Log In
Government Incentive Schemes
2.77B
Log In
Log In
Log In
Log In
Government Incentive Schemes Growth
27.20%
Log In
Log In
Log In
Log In
Scrap
206.00M
Log In
Log In
Log In
Log In
Scrap Growth
-0.34%
Log In
Log In
Log In
Log In
Other
-
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is April - March.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Mar '23 Mar '22 Mar '21 Mar '20 Mar '19
United States
139.80B
Log In
Log In
Log In
Log In
United States Growth
24.36%
Log In
Log In
Log In
Log In
Europe
75.63B
Log In
Log In
Log In
Log In
Europe Growth
4.42%
Log In
Log In
Log In
Log In
Rest of the World
40.56B
Log In
Log In
Log In
Log In
Rest of the World Growth
11.98%
Log In
Log In
Log In
Log In
India
34.02B
Log In
Log In
Log In
Log In
India Growth
23.79%
Log In
Log In
Log In
Log In